Cargando…
Advances in understanding COPD
In recent years, thousands of publications on chronic obstructive pulmonary disease (COPD) and its related biology have entered the world literature, reflecting the increasing scientific and medical interest in this devastating condition. This article is a selective review of several important emerg...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000Research
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5040155/ https://www.ncbi.nlm.nih.gov/pubmed/27746898 http://dx.doi.org/10.12688/f1000research.7018.1 |
_version_ | 1782456199040466944 |
---|---|
author | Anderson, Gary P. |
author_facet | Anderson, Gary P. |
author_sort | Anderson, Gary P. |
collection | PubMed |
description | In recent years, thousands of publications on chronic obstructive pulmonary disease (COPD) and its related biology have entered the world literature, reflecting the increasing scientific and medical interest in this devastating condition. This article is a selective review of several important emerging themes that offer the hope of creating new classes of COPD medicines. Whereas basic science is parsing molecular pathways in COPD, its comorbidities, and asthma COPD overlap syndrome (ACOS) with unprecedented sophistication, clinical translation is disappointingly slow. The article therefore also considers solutions to current difficulties that are impeding progress in translating insights from basic science into clinically useful treatments. |
format | Online Article Text |
id | pubmed-5040155 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | F1000Research |
record_format | MEDLINE/PubMed |
spelling | pubmed-50401552016-10-13 Advances in understanding COPD Anderson, Gary P. F1000Res Review In recent years, thousands of publications on chronic obstructive pulmonary disease (COPD) and its related biology have entered the world literature, reflecting the increasing scientific and medical interest in this devastating condition. This article is a selective review of several important emerging themes that offer the hope of creating new classes of COPD medicines. Whereas basic science is parsing molecular pathways in COPD, its comorbidities, and asthma COPD overlap syndrome (ACOS) with unprecedented sophistication, clinical translation is disappointingly slow. The article therefore also considers solutions to current difficulties that are impeding progress in translating insights from basic science into clinically useful treatments. F1000Research 2016-09-27 /pmc/articles/PMC5040155/ /pubmed/27746898 http://dx.doi.org/10.12688/f1000research.7018.1 Text en Copyright: © 2016 Anderson GP http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Anderson, Gary P. Advances in understanding COPD |
title | Advances in understanding COPD |
title_full | Advances in understanding COPD |
title_fullStr | Advances in understanding COPD |
title_full_unstemmed | Advances in understanding COPD |
title_short | Advances in understanding COPD |
title_sort | advances in understanding copd |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5040155/ https://www.ncbi.nlm.nih.gov/pubmed/27746898 http://dx.doi.org/10.12688/f1000research.7018.1 |
work_keys_str_mv | AT andersongaryp advancesinunderstandingcopd |